New markers of treatment resistance or toxicity are needed in pediatric acute lymphoblastic leukemia (ALL). Pharmacogenetic studies can be useful for childhood ALL because treatment protocols are ...

Children between 2-9 years old who lived within 3.1 miles of wells with high activity faced the greatest risk of developing acute lymphocytic leukemia, compared to those living farther away from ...

B-cell acute lymphoblastic leukemia (B-ALL) is a life-threatening and highly aggressive form of blood cancer. It is the most common childhood cancer, making up 35% of pediatric cancer cases ...

Using data from its Colorado Central Cancer Registry, Colorado Department of Public Health and Environment (CDPHE) staff identified 451 children between the ages of 2 and 9 with confirmed diagnoses of ...

2024 — Scientists have identified novel genetic variations that influence relapse risk in children with standard risk B-cell acute lymphoblastic leukemia (SR B-ALL), the most common childhood ...

Every morning at 9:30 a.m., Ivy goes to work at the Tokyo Metropolitan Children’s Medical ... who had developed acute lymphocytic leukemia, was urgently hospitalized. Four days later, Ivy ...

And you decided to focus on childhood leukemia and really this one type of leukemia in particular? Yes, so this is acute lymphocytic leukemia. We call it ALL for short. And it’s the most common ...

(Figure 3) Figure 1. Five-year net survival (%) in patients diagnosed with colon cancer, female breast cancer, and acute lymphoblastic leukemia (children) in 2010–2014 CONCORD-3 study worldwide. Colon ...

Researchers are looking into new treatments for acute lymphoblastic leukaemia as well as ways to reduce the side effects treatment can cause. There are a number of clinical trials for children to join ...